NEA Management Company, LLC Q3 2019 Filing
Filed October 11, 2019
Portfolio Value
$1.2T
Holdings
46
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (46 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALLKGUSDALLAKOS INC | 2,268,188 | $178.3B | 14.77% | |
| 2 | —RA PHARMACEUTICALS INC | 6,138,797 | $145.2B | 12.02% | |
| 3 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $106.1B | 8.78% | |
| 4 | CRSPCRISPR THERAPEUTICS AG | 2,090,678 | $85.7B | 7.10% | |
| 5 | NETCLOUDFLARE INC | 4,059,376 | $75.4B | 6.24% | |
| 6 | ARDXARDELYX INC | 15,335,047 | $72.1B | 5.97% | |
| 7 | —EPIZYME INC | 4,377,518 | $45.2B | 3.74% | |
| 8 | MIRMMIRUM PHARMACEUTICALS INC | 4,187,801 | $42.1B | 3.49% | |
| 9 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $39.2B | 3.24% | |
| 10 | —OBSEVA SA | 4,586,563 | $38.2B | 3.16% | |
| 11 | SENS1GBPSENSEONICS HOLDINGS INC | 30,888,266 | $30.6B | 2.53% | |
| 12 | —PHASEBIO PHARMACEUTICALS INC | 6,643,704 | $27.7B | 2.29% | |
| 13 | AUPHAURINIA PHARMACEUTICALS INC | 5,172,683 | $27.6B | 2.29% | |
| 14 | TPIVDEURMARKER THERAPEUTICS INC | 5,000,000 | $25.6B | 2.12% | |
| 15 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 15,832,611 | $23.9B | 1.98% | |
| 16 | —DERMIRA INC | 3,506,649 | $22.4B | 1.86% | |
| 17 | —AVEO PHARMACEUTICALS INC | 25,243,865 | $21.3B | 1.77% | |
| 18 | —GENOCEA BIOSCIENCES INC | 7,225,676 | $21.0B | 1.73% | |
| 19 | TRVITREVI THERAPEUTICS INC | 4,441,360 | $20.0B | 1.65% | |
| 20 | —MERSANA THERAPEUTICS INC | 11,963,649 | $18.9B | 1.57% | |
| 21 | —AFFIMED NV | 5,138,888 | $15.1B | 1.25% | |
| 22 | —MILLENDO THERAPEUTICS INC | 1,766,779 | $12.6B | 1.04% | |
| 23 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $9.9B | 0.82% | |
| 24 | —SYNLOGIC INC | 4,229,410 | $9.7B | 0.80% | |
| 25 | MEIPUSDMEI PHARMA INC | 5,720,572 | $9.6B | 0.80% | |
| 26 | LQDALIQUIDIA TECHNOLOGIES INC | 2,486,062 | $8.8B | 0.73% | |
| 27 | CSBRCHAMPIONS ONCOLOGY INC | 1,562,500 | $8.8B | 0.73% | |
| 28 | —DASAN ZHONE SOLUTIONS INC | 956,255 | $8.8B | 0.73% | |
| 29 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $7.2B | 0.59% | |
| 30 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $6.1B | 0.50% | |
| 31 | VRNAVERONA PHARMA PLC | 1,219,674 | $5.6B | 0.46% | |
| 32 | XENEXENON PHARMACEUTICALS INC | 602,663 | $5.4B | 0.45% | |
| 33 | SURFUSDSURFACE ONCOLOGY INC | 3,315,149 | $4.7B | 0.39% | |
| 34 | —PROTEOSTASIS THERAPEUTICS INC | 5,556,778 | $4.7B | 0.39% | |
| 35 | BEBLOOM ENERGY CORP | 1,333,333 | $4.3B | 0.36% | |
| 36 | ASNSUSDX4 PHARMACEUTICALS INC | 333,333 | $4.2B | 0.35% | |
| 37 | —TREVENA INC | 3,811,691 | $3.7B | 0.31% | |
| 38 | CTIC1USDCTI BIOPHARMA CORP | 3,750,000 | $3.1B | 0.26% | |
| 39 | ERYP1EURERYTECH PHARMA SA | 625,000 | $2.6B | 0.22% | |
| 40 | —TRACON PHARMACEUTICALS INC | 3,467,181 | $1.6B | 0.13% | |
| 41 | —REGULUS THERAPEUTICS INC | 2,052,455 | $1.5B | 0.12% | |
| 42 | —ENDOLOGIX INC | 249,021 | $989.0M | 0.08% | |
| 43 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $935.0M | 0.08% | |
| 44 | —AKARI THERAPEUTICS PLC | 452,167 | $773.0M | 0.06% | |
| 45 | TREURTRILLIUM THERAPEUTICS INC | 2,100,000 | $646.0M | 0.05% | |
| 46 | —ACHAOGEN INC | 5,215,128 | $63.0M | 0.01% |